Establishment of pregnancy in ruminants requires conceptus elongation and production of interferon tau (IFNT), the pregnancy recognition signal that maintains the corpus luteum and progesterone (P4) secretion. The enzymes hydroxysteroid (11-beta) dehydrogenase 1 (HSD11B1) and HSD11B2 catalyze the interconversion of inactive cortisone and active cortisol, which is a biologically active glucorticoid and ligand for the receptor subfamily 3, group C, member 1 (glucocorticoid receptor) (NR3C1). The activity of HSD11B1 is stimulated by P4, prostaglandins, and cortisol. These studies determined the effects of pregnancy, P4, and IFNT on HSD11B1, HSD11B2, prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (PTGS2), and nuclear NR3C1 in the ovine uterus. Endometrial HSD11B1 mRNA levels were more abundant between Days 12 and 16 of pregnancy than the estrous cycle, and HSD11B1 and PTGS2 expression in the endometrial luminal and superficial glandular epithelia was coincident with conceptus elongation. HSD11B1 mRNA was very low in the conceptus, whereas HSD11B2 mRNA was abundant in the conceptus but not in the uterus. Treatment of ewes with P4 induced, and intrauterine infusions of IFNT modestly stimulated, HSD11B1 expression in the endometrial luminal and superficial glandular epithelia. In all of the studies, HSD11B1 and PTGS2 expression was coincident in the endometrial epithelia, and NR3C1 was present in all endometrial cell types. Collectively, these results support hypotheses that endometrial epithelial HSD11B1 expression is induced by P4 as well as stimulated by IFNT and PTGS2-derived prostaglandins and that HSD11B1-regenerated cortisol acts via NR3C1 to regulate ovine endometrial functions during early pregnancy. pregnancy, progesterone, steroid hormone receptors, trophoblast, uterus
INTRODUCTION
Maternal support of blastocyst growth and development into an elongated conceptus (embryo/fetus and associated membranes) is critical for pregnancy recognition signaling and implantation in ruminants [1, 2] . After hatching from the zona pellucida on Day 8, the blastocyst develops into an ovoid or tubular form by Day 11 and is then termed a conceptus [1, 3] . The conceptus begins to elongate on Day 12 and reaches 14 cm or more in length by Day 16. Conceptus elongation requires substances secreted from the endometrial luminal (LE) and glandular epithelia (GE) [4, 5] . During early pregnancy in ruminants, functions of endometrial epithelia are regulated primarily by progesterone (P4) from the corpus luteum (CL) and secreted factors from the conceptus trophectoderm such as interferon tau (IFNT) [6] [7] [8] . Interferon tau, produced by the mononuclear trophectoderm cells of the conceptus during elongation, exerts antiluteolytic effects on the endometrium to inhibit production of luteolytic pulses of prostaglandin F2 alpha (PGF2a), thereby maintaining CL function for continued production of P4 that, in turn, stimulates and maintains uterine endometrial functions necessary for conceptus survival, growth, implantation, placentation, and successful development of the fetus to term [6] . In addition to exerting an antiluteolytic effect, IFNT induces or increases expression of many genes in the endometrial epithelia that regulate conceptus growth and development during the peri-implantation period of pregnancy (for review, see [2, 8, 9] ).
We recently reported results from an ovine model of accelerated blastocyst growth and conceptus development elicited by advancing the postovulatory increase in circulating levels of P4 during metestrus [10] . That model was used to identify a number of P4-regulated genes that are expressed in the endometrial epithelia (LE, superficial glandular epithelia (sGE), and/or GE) and encode secreted proteins-galectin 15 (LGALS15), gastrin-releasing peptide (GRP), insulin-like growth factor one (IGFBP1), and IGFBP3-that are hypothesized to regulate conceptus elongation via effects on trophectoderm proliferation, migration, and/or attachment [10] [11] [12] [13] [14] . In addition to genes encoding secreted proteins, microarray analysis identified HSD11B1 (hydroxysteroid (11-beta) dehydrogenase 1) as a candidate P4-regulated gene (Satterfield et al., see Note Added in Proof ). HSD11B1 is one of two isoforms of 11-beta-hydroxysteroid dehydrogenase that modulate the actions of glucocorticoids (cortisol and cortisone) within potential target cells (for review, see [15] ). HSD11B1 acts predominantly as a NADP(H)-dependent reductase to generate active cortisol from inactive cortisone, whereas HSD11B2 acts predominantly to generate inactive cortisone from active cortisol. Cortisol can activate both the glucocorticoid receptor (nuclear receptor subfamily 3, group C, member 1 or NR3C1 or GR) and the mineralocorticoid receptor (nuclear receptor subfamily 3, group C, member 2 or NR3C2 or MR). Although NR3C1 and NR3C2 expression has not been reported for the ovine uterus during early pregnancy, HSD11B1 was previously found to be expressed in the endometrial LE and upper GE of the ovine uterus during the estrous cycle and early pregnancy [16] . In fact, the pattern of expression during the estrous cycle and pregnancy led those investigators to hypothesize that HSD11B1 expression was regulated by P4, although no evidence was presented to support that hypothesis. In the ovine placenta, prostaglandins can stimulate HSD11B1 activity and glucocorticoids can increase prostaglandin synthesis by up-regulating expression and activities of phospholipase A2 and prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (PTGS2) [17] , thereby establishing a positive feed-forward loop implicated in the timing of parturition [18] . This tissue-specific stimulatory role of glucocorticoids on synthesis of prostaglandins is in contrast to the classic anti-inflammatory, suppressive action of glucocorticoids on synthesis of prostaglandins in immune cells. Recent studies in the bovine uterus also found that prostaglandins regulate HSD11B1 activity in the endometrium [19] . In sheep, elongation of the conceptus is coincident with PTGS2 expression in the endometrial epithelia and prostaglandin production by the conceptus [20] [21] [22] .
Collectively, the available evidence supports the working hypotheses that P4 and prostaglandins control HSD11B1 expression in the endometrial epithelia and that cortisol generated from cortisone by HSD11B1 acts via NR3C1 to regulate endometrial functions important for conceptus elongation and implantation during the peri-implantation period of pregnancy. As a first step in testing these hypotheses, the present studies determined effects of pregnancy, P4, and IFNT on the expression of HSD11B1, HSD11B2, PTGS2, and NR3C1 in the ovine uterus.
MATERIALS AND METHODS

Experimental Design
All experimental and surgical procedures were in compliance with the Guide for the Care and Use of Agriculture Animals in Research and Teaching and approved by the Institutional Animal Care and Use Committee of Texas A&M University. Study 1. At the onset of estrus (Day 0), Suffolk cross-bred ewes were mated to either an intact or vasectomized ram and then hysterectomized (n ¼ 5 ewes/day) on either Day 3, 6, 10, 12, 14, or 16 of the estrous cycle or Day 10, 12, 14, 16, 18, or 20 of pregnancy, and uterine and/or conceptus tissues were processed as described previously [23] . At hysterectomy, pregnancy was confirmed by the presence of a morphologically normal blastocyst/conceptus in the uterine flushing. Several sections (;0.5 cm) from the midportion of each uterine horn ipsilateral to the CL were fixed in fresh 4% paraformaldehyde in PBS (pH 7.2). After 24 h, fixed tissues were changed to 70% ethanol for 24 h and then dehydrated and embedded in Paraplast-Plus (Oxford Labware, St. Louis, MO). The remaining endometrium was physically dissected from myometrium, frozen in liquid nitrogen, and stored at À808C for subsequent RNA extraction. Study 2. Cyclic ewes (n ¼ 4) were mated at estrus (Day 0) to a fertile ram. Blood samples were taken daily by jugular venipuncture until Day 20 postmating. Serum was collected after clotting at 48C for 4 h and clarified by centrifugation (3000 3 g for 30 min at 48C) before storage at À208C. All ewes were subsequently confirmed pregnant by transrectal ultrasonography on Day 35 of gestation. Study 3. As described previously [10] , ewes were mated at estrus (Day 0) to intact rams and then assigned randomly to receive daily intramuscular (i.m.) injections from Days 1.5 to 9 of either corn oil vehicle (CO; n ¼ 6) or 25 mg P4 (Sigma Chemical Co., St. Louis, MO; n ¼ 6); all ewes were hysterectomized on Day 9. An additional group of ewes were mated and assigned randomly to receive daily i.m. injections of either: (a) CO (n ¼ 8), (b) 25 mg P4 from Days 1.5 to 12 (n ¼ 7), or (c) 25 mg P4 (from Days 1.5 to 8, n ¼ 5) and 75 mg of RU486 (mifepristone; Sigma-Aldrich, Inc., St. Louis, MO), a P4 receptor (PGR) and NR3C1 antagonist [24] , from Days 8 to 12 (P4þRU); all ewes were hysterectomized on Day 12. Uteri were processed as described for study 1. Pregnancy was confirmed by the recovery of a morphologically normal blastocyst or conceptus in the uterine flushing. Recombinant ovine IFNT was produced in Pichia pastoris and purified as described previously [25] . Serum proteins and IFNT were prepared for i.u. injections as described previously [26] . This regimen of P4 and IFNT mimics the effects of P4 and IFNT from the CL and conceptus, respectively, on endometrial expression of hormone receptors and IFNT-stimulated genes during early pregnancy in ewes [27] . All ewes were hysterectomized on Day 17, and the uteri were processed as described for study 1.
Cortisol Radiommunoassay
Serum concentrations of cortisol were measured in samples from study 2 by routine methods employing a solid phase radioimmunoassay as per manufacturer's instructions (TKC02, Siemens Diagnostic Products Corporation; Deerfield, IL). The minimum detectable concentration of cortisol was 1.2 ng/ml and the intraassay coefficient of variation was 3.8%. Tubes were placed in Packard Cobra II auto gamma counter to determine counts per minute (i.e., counts per minute bound). Concentrations of cortisol in serum were determined by comparison to a standard curve generated using known concentrations of cortisol (Assay Zap, Biosoft, Cambridge, U.K.). Data are presented as cortisol in ng/ml.
RT-PCR of Ovine HSD11B1 and HSD11B2 cDNAs
Partial cDNAs for ovine HSD11B1 and HSD11B2 mRNAs were amplified by RT-PCR using total RNA isolated from Day 18 pregnant ewes as described previously [11] . For HSD11B1, the sense primer (5 0 -CAT TCT GGG GAT CTT CTT GG-3 0 ) and antisense primer (5 0 -GAA TAG GCA GCA GCA AGT GG-3 0 ) were derived from the Ovis aries HSD11B1 mRNA coding sequence (GenBank accession no. NM_001009395) and amplified a 534 bp product. For HSD11B2, the sense primer (5 0 -AGT TCA CCA AGG TCC ACA CC-3 0 ) and antisense primer (5 0 -TGC TCG ATG TAG TCC TCA CC-3 0 ) were derived from the O. aries HSD11B2 mRNA coding sequence (GenBank accession no. NM_001009460) and amplified a 457 bp product. Partial ovine cDNAs were cloned into pCRII using a T/A Cloning Kit (Invitrogen, Carlsbad, CA), and sequences were verified using an ABI PRISM Dye Terminator Cycle Sequencing Kit and ABI PRISM automated DNA sequencer (Perkin-Elmer Applied Biosystems, Foster City, CA).
Slot Blot Hybridization Analysis
Total cellular RNA was isolated from frozen endometrium using Trizol reagent (Gibco-BRL, Bethesda, MD) according to manufacturer's instructions. The quantity and quality of total RNA was determined by spectrometry and denaturing agarose gel electrophoresis, respectively. Steady-state levels of HSD11B1 mRNA were assessed by slot blot hybridization using radiolabeled antisense HSD11B1 and 18S cRNA probes as described previously [28] . Radiolabeled antisense cRNA probes were generated by in vitro transcription using linearized partial plasmid cDNA templates, RNA polymerases, and [a-32 P]-UTP. Radioactivity associated with slots was quantified using a Typhoon 8600 MultiImager (Molecular Dynamics, Piscataway, NJ). Data are expressed as relative units.
In Situ Hybridization Analysis
Cell-specific expression of HSD11B1 and HSD11B2 mRNAs in ovine uteri was determined using radioactive in situ hybridization analysis as described previously [12, 28] . Radiolabeled antisense and sense cRNA probes were generated by in vitro transcription using linearized partial plasmid cDNA templates, RNA polymerases, and [a- 35 S]-UTP. All the slides for each respective gene were exposed to photographic emulsion for the same period of time. Images of representative fields were recorded under brightfield and darkfield illumination using a Nikon Eclipse 1000 photomicroscope (Nikon Instruments Inc., Lewisville, TX) fitted with a Nikon DXM1200 digital camera.
Immunohistochemical Analyses
Immunoreactive PTGS2 and NR3C1 proteins were localized in ovine uteri using a rabbit anti-murine PTGS2 polyclonal antibody (Catalog No. 160106; Cayman Chemical, Ann Arbor, MI) at a 1:250 final dilution or a mouse anti-rat NR3C1 monoclonal antibody (Catalog No. MA1-510; Affinity Bioreagents, Golden, CO) at 5 lg/ml and Rabbit or Mouse Vectastain ABC Elite Kit (Vector Laboratories, Burlingame, CA). Antigen retrieval for both PTGS2 and NR3C1 was performed using the boiling citrate method as described previously [23] . Negative controls included substitution of the primary antibody with purified nonimmune rabbit or mouse IgG at the same final concentration. Sections were not counterstained prior to affixing the coverslips. 
Statistical Analyses
All quantitative data were subjected to least-squares analyses of variance (ANOVA) using the Statistical Analysis System (SAS Institute, Cary, NC). Slot blot hybridization data were corrected for differences in sample loading using the 18S rRNA data as a covariate. Data from ewes between Days 12 and 16 (study 1) were analyzed for effects of day, pregnancy status (cyclic or pregnant), and their interaction. Data from study 2 were analyzed for effects of day of pregnancy using regression analysis. Data from studies 3 and 4 were analyzed using orthogonal contrasts (Day 9: CO vs. P4, Day 12: CO vs. P4, and Day 12: P4 vs. P4þRU486 for study 2; and P4þCX vs. P4þIFN, P4þRUþCX vs. P4þRUþIFN, P4þCX vs. P4þRUþCX for study 3) to elucidate the effects of treatment. All the tests of significance were performed using the appropriate error terms according to the expectation of the mean squares for the error. A P-value of 0.05 or less was considered significant. Data are presented as leastsquare means with overall standard errors.
RESULTS
HSD11B1, HSD11B2, PTGS2, and NR3C1 in the Ovine Uterus during the Cycle and Early Pregnancy HSD11B1. As illustrated in Figure 1 , endometrial HSD11B1 mRNA levels were low to undetectable on Days 3, 6, and 10, increased 7.3-fold between Days 10 and 12, increased another 10.8-fold between Days 12 and 14, and remained elevated to Day 16 in cyclic ewes (cubic effect of day, P , 0.01). As compared to cyclic ewes, HSD11B1 mRNA levels were 11.3-fold higher on Day 12, 2.0-fold higher on Day 14, and 2.4-fold higher on Day 16 of pregnancy (day x status, P , 0.01); increased from Day 12 to a maximum on Days 14 and 16; and then declined to Day 20 (quadratic effect of day, P , 0.01).
In situ hybridization analysis revealed that HSD11B1 mRNA was most abundant in uterine LE, sGE, and upper GE, with lower abundance in the middle to deep GE, stroma, and myometrium ( Fig. 2A) . HSD11B1 mRNA was consistently more abundant in intercaruncular LE/sGE than caruncular LE of endometria. In Day 18 and 20 conceptuses, HSD11B1 mRNA was detectable in very low abundance.
HSD11B2. In situ hybridization analysis found HSD11B2 mRNA present at very low levels in all cell types of uteri of both cyclic and pregnant ewes (Fig. 2B) ; thus, steady-state levels of HSD11B2 mRNA were not measured. In contrast to the uterus, HSD11B2 mRNA was detected in trophectoderm and endoderm of Day 18 and 20 conceptuses.
PTGS2. Immunoreactive PTGS2 protein detected only in uterine LE/sGE and upper GE was distributed throughout the cytoplasm of these cells (Fig. 3) . In cyclic ewes, PTGS2 was low in uterine LE/sGE on Day 10, increased to maximal abundance on Day 12, and then declined to Day 16. In uteri from pregnant ewes, PTGS2 was also low in uterine LE/sGE on Day 10, increased to maximal abundance on Day 14, and then declined to nearly undetectable levels on Day 20. On both Days 14 and 16, PTGS2 was more abundant in uterine LE/sGE and upper GE of pregnant as compared to cyclic ewes. In Day 18 and 20 conceptuses, PTGS2 was detected in the trophectoderm and was particularly abundant in the inner cell mass.
NR3C1. Immunoreactive NR3C1 (GR) protein was detected in the nuclei of most, if not all, cell types in the endometrium and myometrium (Fig. 3) . In cyclic ewes, NR3C1 protein was most abundant in the endometrial epithelia on Days 10 and 12. After Day 12, NR3C1 protein abundance decreased in the endometrium, particularly in the epithelia. In pregnant ewes, NR3C1 protein was most abundant in the endometrial epithelia on Day 10, and then its abundance declined. After Day 12, NR3C1 was most abundant in the middle to deep GE, stroma, and myometrium, and was present at low abundance in the LE, sGE, and upper GE of the endometrium. NR3C1 was also detected in the nuclei of trophectoderm cells of conceptuses from Days 18 and 20 of pregnancy.
Concentrations of Cortisol in the Circulation
As illustrated in Figure 4 , concentrations of cortisol in the serum of ewes were highest on Day 1 (;27 ng/ml) and then declined to between 5 and 15 ng/ml between Days 5 and 20 of pregnancy (quadratic effect of day, P , 0.01).
HSD11B1 Is Induced by P4 and Stimulated by IFNT
The temporal changes in endometrial HSD11B1 mRNA in uterine epithelia of cyclic and early pregnant ewes detected in study 1 suggested that endometrial HSD11B1 expression is regulated by P4 and a factor from the conceptus. Therefore, a sheep model in which concentrations of P4 in the circulation are prematurely elevated after estrus by treatment with exogenous P4 from Day 1.5 postmating was used in study 3 because the early P4 treatment is known to increase blastocyst size on Day 9 and conceptus growth into an elongated filamentous form on Day 12 that secretes more IFNT [10] . As illustrated in Figure 5A , HSD11B1 mRNA abundance was 2-fold (CO vs. P4, P , 0.01) greater in early P4-treated ewes on Day 9, 2.4-fold (CO vs. P4, P , 0.01) greater on Day 12, and 5.0-fold (P4 vs. P4þRU486, P , 0.001) higher in P4 than P4þRU486-treated ewes on Day 12. In situ hybridization analysis revealed that HSD11B1 mRNA was most abundant in uterine LE/sGE of CO-and P4-treated ewes on Day 12 (Fig.  5B ). PTGS2 protein in uterine LE/sGE was also greater in P4-treated ewes on both Days 9 and 12, more abundant in Day 12 than Day 9 CO-treated ewes, but much less abundant to undetectable on Day 12 in ewes receiving P4 and RU486. NR3C1 protein was detected in all endometrial cell types and was more abundant in uterine LE/sGE of Day 9 and 12 early P4-treated ewes. Moreover, NRC3C1 protein was less abundant, particularly in uterine epithelia, of Day 12 ewes treated with P4 and RU486 as compared to uteri from Day 12 ewes receiving CO or early P4 treatments.
Study 4 was with a model used extensively by our laboratory to determine if genes are regulated by P4 and IFNT [27] . As illustrated in Figure 6A , endometrial HSD11B1 mRNA abundance was 3.3-fold (P4þCX vs. P4þRUþCX, P , 0.01) greater in ovariectomized ewes treated with P4 for 12 days. Further, endometrial HSD11B1 mRNA levels were FIG. 1. Steady-state levels of HSD11B1 mRNA in endometria of cyclic and pregnant ewes. Endometrial HSD11B1 mRNA abundance was determined by slot blot hybridization analysis (see Materials and Methods). Between Days 12 and 16, HSD11B1 mRNA was more abundant in pregnant than cyclic ewes (day x status, P , 0.01).
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2.2-fold greater (P4þCX vs. P4þIFNT, P , 0.01) in P4-treated ewes receiving intrauterine infusions of IFNT, but not in ewes receiving P4 and RU486 (P4þRUþCX vs. P4þRUþIFNT, P . 0.10). In situ hybridization analysis revealed that the effects of P4 in inducing, and of IFNT in stimulating, HSD11B1 expression were confined to uterine LE/ sGE and upper GE (Fig. 6B) . In ewes receiving P4 and RU486, HSD11B1 mRNA detected in the subepithelial stroma was localized primarily to immune cells.
As observed in study 3, the effects of treatments on PTGS2 and NR3C1 abundance paralleled those for HSD11B1 mRNA in uterine LE/sGE and upper GE of P4-treated ewes (Fig. 6B) . In P4-treated ewes, PTGS2 and NR3C1 proteins were more abundant in uterine LE/sGE of ewes that were also treated with intrauterine infusions of IFNT. In ewes receiving intrauterine infusions of CX proteins, PTGS2 and NR3C1 proteins were higher in uterine LE/sGE of ewes receiving P4 than P4 and RU486.
FIG. 2. In situ hybridization analysis of (A)
HSD11B1 (B) and HSD11B2 mRNAs in uteri of cyclic and pregnant ewes. Crosssections of the uterine wall from cyclic (C) and pregnant (P) ewes were hybridized with radiolabeled antisense or sense ovine cRNAs. Note that HSD11B1 mRNA is most abundant in the endometrial LE and sGE, whereas HSD11B2 mRNA is most abundant in the conceptus during early pregnancy. C, caruncle; LE, luminal epithelium; sGE, superficial glandular epithelium; GE, middle to deep glandular epithelium; S, stroma; Tr, trophectoderm. All photomicrographs are at the same width of field (560 lm).
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DISCUSSION
The results of the present studies support the hypothesis that P4, IFNT, and PTGS2-derived prostaglandins regulate HSD11B1 expression in uterine LE/sGE. In studies 3 and 4, HSD11B1 mRNA was induced by P4 in uterine LE/sGE, but this effect was blocked by administration of RU486, a PGR and NR3C1 antagonist [24] . In both studies, HSD11B1 mRNA and PTGS2 protein were absent from the endometrial epithelia of ewes treated with RU486. Stimulation of PTGS2 expression by P4 in ovine uteri was reported previously [20, 29] . Although postulated previously [16] , the present studies are the first to demonstrate that P4 induces HSD11B1 expression in uterine LE/sGE. Paradoxically, the increase in HSD11B1 and PTGS2 expression in uterine LE/sGE between Days 10 and 12 of the cycle and pregnancy is temporally associated with loss of PGR expression in these epithelia [10, 30, 31] . Continuous exposure of the sheep uterus to P4 for 8 to 10 days is required for loss of PGR in endometrial epithelia, which does not occur in the stroma or myometrium [32, 33] . Loss of PGR in ovine uterine LE/sGE between Days 10 and 12 is associated with the onset of expression of HSD11B1 and several other genes, including PTGS2, LGALS15, GRP, IGFBP1, solute carrier family 2 (facilitated glucose transporter), member 1 (SLC2A1), solute carrier family 5 (sodium/glucose cotransporter), member 1 (SLC5A1), and solute carrier family 7 (cationic amino acid transporter, yþ system), member 2 (SLC7A2), that are implicated as regulators of cellular processes involved in conceptus elongation [10-12, 14, 20, 34-36] . In addition to being an antiprogestin, RU486 is also a high affinity antagonist of NR3C1 [24] , and loss of expression of NR3C1 as well as HSD11B1 mRNAs occurred in endometria of ewes treated with RU486 in both studies 3 and 4. It is possible that effects of P4 on HSD11B1 and PTGS2 expression are mediated by NR3C1 because P4 regulates gene expression in human trophoblast cell   FIG. 3 . Immunohistochemical analysis of PTGS2 and NR3C1 proteins in uteri of cyclic and pregnant ewes. Cross-sections of the uterine wall from cyclic (C) and pregnant (P) ewes were used for immunohistochemical analyses employing specific antibodies or nonimmune IgG as a control (see Materials and Methods). Sections were not counterstained. LE, luminal epithelium; sGE, superficial glandular epithelium; GE, middle to deep glandular epithelium; ICM, inner cell mass; M, myometrium; S, stroma; Tr, trophectoderm. All photomicrographs are at the same width of field (280 lm).
FIG. 4.
Concentrations of cortisol in the circulation of early pregnant ewes. Serum cortisol was measured using a specific radioimmunoassay (see Materials and Methods), and concentriations were highest on Day 1, declined through Day 6 and remained constant thereafter (quadratic effect of day, P , 0.05).
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via an interaction with NR3C1 [37, 38] . The effects of a specific NR3C1 antagonist on uterine gene expression and function during early pregnancy has not been reported in sheep, although the RU486 treatment used in study 3 elicited embryonic death in sheep [10] .
In study 1, HSD11B1 mRNA and PTGS2 abundance in uterine LE/sGE was clearly increased by the presence of a conceptus as early as Day 12. IFNT, a novel member of the type I IFN family, is the most abundant protein secreted by the elongating conceptus [39] . In study 3, expression of HSD11B1 and PTGS2 in endometria was greater in early P4-treated ewes on Day 12 that also had an elongating, filamentous conceptus in the uterus producing more IFNT as compared to control ewes containing a smaller ovoid conceptus producing little or FIG. 5. Effects of progesterone (P4) during early pregnancy on HSD11B1 mRNA, PTGS2 protein, and NR3C1 protein in ovine uteri. A) Steady-state levels of HSD11B1 mRNA in endometria were determined by slot blot hybridization analysis. In ewes treated to both Days 9 and 12, the abundance of HSD11B1 mRNA in endometrial increased 2-fold and 2.3-fold, respectively, in response to P4 (CO vs. P4, P , 0.01). Treatment of ewes with the antiprogestin RU486 from Days 8 to 12 reduced the abundance of endometrial HSD11B1 mRNA by 5.0-fold (P4 vs. P4þRU486, P , 0.01) compared to P4-treated ewes. The asterisk denotes an effect of treatment (*P , 0.01). B) In situ hybridization analysis of HSD11B1 mRNA and immunohistochemical analysis of PTGS2 and NR3C1 proteins. LE, luminal epithelium; sGE, superficial glandular epithelium; GE, glandular epithelium; S, stroma. Photomicrographs of in situ hybridization analysis are displayed at the same width of field (560 lm), whereas those of the immunohistochemical analysis are at 280 lm. 40 no IFNT [10] . In study 4, infusion of recombinant ovine IFNT into uteri of P4-treated ewes increased the abundance of HSD11B1 mRNA in the endometrial LE/sGE. Collectively, the results of the present studies indicate that HSD11B1 is another P4-induced and IFNT-stimulated gene in the endometrial LE/ sGE and upper GE along with LGALS15, GRP, IGFBP1, SLC2A1, SLC5A1, and SLC7A2 [11, 14, [34] [35] [36] . The mechanism whereby IFNT stimulates expression of those genes in the LE/sGE and upper GE of the endometrium is not known. The canonical janus kinase-signal transducer and activator of transcription (JAK-STAT) signaling pathway used by type I IFNs is not active in the endometrial LE/sGE and upper GE of the ovine uterus during early pregnancy because several essential transcription factors-STAT1, STAT2, and IFN regulatory factor 9 (IRF9)-that form the IFN-stimulated gene factor 3 transactivator complex and that mediate canonical type I IFN signaling are not expressed in those epithelia due to expression of IRF2, a potent transcriptional repressor [40, 41] . Thus, IFNT likely regulates endometrial LE/sGE gene expressing using a noncanonical signaling pathway, such as mitogen-activated protein kinase p38 cascade and the phosphatidylinositol 3-kinase cascade reported for other IFNs [42] .
When comparing results of studies 1 and 4, it was apparent that the 2-fold increase in HSD11B1 mRNA levels in endometrial elicited by intrauterine infusions of IFNT in ewes   FIG. 6 . Effects of progesterone and IFNT on HSD11B1 mRNA and PTGS2 and NR3C1 proteins in ovine uteri. A) Steadystate levels of HSD11B1 mRNA in endometria were determined by slot blot hybridization analysis. Treatment of ewes with progesterone (P4) increased (*P , 0.01) endometrial HSD11B1 mRNA abundance as compared to ewes receiving P4 and the antiprogestin RU486. Intrauterine IFNT increased HSD11B1 mRNA (P , 0.01) in P4-treated ewes, but not in P4þRU486-treated ewes. B) In situ hybridization analysis of HSD11B1 mRNA and immunohistochemical analysis of PTGS2 and NR3C1 proteins. LE, luminal epithelium; sGE, superficial glandular epithelium; GE, glandular epithelium; S, stroma. Photomicrographs of in situ hybridization analysis and PTGS2 immunolocalization are at the same width of field (560 lm), whereas those for immunolocalization of NR3C1 are at 280 lm.
HSD11B1, PTGS2, AND NR3C1 IN THE OVINE UTERUS treated with P4 was modest compared to the 11.3-fold increase in HSD11B1 mRNA in the endometria of Day 12 pregnant as compared to Day 12 cyclic ewes. Ovoid and tubular ovine conceptuses on Day 12 of pregnancy produce little IFNT compared to the large amounts produced by elongating conceptuses on Days 14 and 16 of pregnancy [43] . Thus, another factor produced by the ovine conceptus likely regulates expression of HSD11B1, with prostaglandins being a strong candidate. The trophectoderm cells of ovine conceptuses contain abundant PTGS2 [21] and synthesize and secrete a number of different prostaglandins, including PGE2 and PGF2a [22, 44] . In pregnant ewes, the increase in HSD11B1 expression by uterine LE/sGE between Days 10 and 14 of pregnancy and the subsequent decline in expression between Days 16 and 20 is temporally associated with the pattern of production of prostaglandins by ovine conceptuses and the amounts of these prostaglandins in the uterine lumen [21, 45, 46] . In the endometrial LE/sGE, changes in PTGS2 abundance are coincident with HSD11B1 expression. Of particular note, HSD11B1 expression and/or bioactivity in the ovine placenta is stimulated by a positive feedback loop involving cortisol and prostaglandins as well as proinflammatory cytokines (interleukin one beta or IL1B and tumor necrosis factor or TNF) and P4 (for review, see [15, 17] ), thereby establishing a positive feedforward loop implicated in the timing of parturition [18] . Given that the concentrations of cortisol in the circulation do not increase in ewes during early pregnancy (study 4), it is unlikely that circulating cortisol alone stimulates endometrial expression of HSD11B1 in an endocrine manner. However, the available results indicate that HSD11B1 expression in ovine uterine LE/sGE and upper GE during early pregnancy is regulated by IFNT and prostaglandins from the elongating conceptus and HSD11B1-regenerated cortisol within the endometrial epithelia itself.
In addition to conceptus-derived prostaglandins, endometrial-derived prostaglandins may also regulate HSD11B1 expression because changes in HSD11B1 mRNA and PTGS2 protein are coincident in uterine LE/sGE and upper GE during the estrous cycle. Both pregnant and nonpregnant ovine endometria synthesize and secrete prostaglandins [47] [48] [49] . In nonpregnant bovine endometrium, PGF2a stimulates HSD11B1 activity [19] . In placentae, cortisol increases prostaglandin synthesis [50, 51] by stimulating PTGS2 transcription [52] . Thus, increased abundance of PTGS2 between Days 12 and 16 of the estrous cycle and pregnancy in endometrial LE/sGE in study 1 could be due to higher levels of prostaglandins, HSD11B1, and cortisol in those epithelia. Moreover, active cortisol generated from inactive cortisone by HSD11B1 in uterine LE/sGE could activate NR3C1 and regulate expression of target genes, as PGR are absent from those epithelia. Future studies should focus on the biological roles of cortisol and prostaglandins in regulation of HSD11B1 and PTGS2 expression and bioactivity in ovine uteri during the estrous cycle and early pregnancy. Finally, it is possible that other factors within the endometrium and from the conceptus regulate HSD11B1 and PTGS2 expression in the ovine uterus.
The results of the present studies established the presence of both HSD11B1 and NR3C1 in the ovine endometria during early pregnancy; however, the biological roles of HSD11B1-regenerated cortisol and NR3C1 are unknown at present. Despite extensive studies of the developmental consequences of increased glucocorticoid exposure of pregnant sheep, relatively little is known regarding the significance of HSD11B1 and glucocorticoids in early pregnancy in any species [15, 17] . The physiological role for placental HSD11B1 in parturition is clearly delineated in its physiological role from placental HSD11B2 regarding protection of the fetus from excess cortisol (for review, see [17] ). Moreover, HSD11B2 is expressed and functional in first trimester trophoblast cells of human placentae where it has been implicated in successful embryo attachment and implantation [53] . Glucocorticoids are hypothesized to exert many actions that could both negatively and positively affect key aspects of early pregnancy (for review, see [17] ). The positive effects of glucocorticoids would promote pregnancy (e.g., stimulate chorionic gonadotropin secretion, immunosuppression, trophoblast growth/invasion, and amino acid transport), whereas the negative effects would compromise the pregnancy (e.g., inhibit cytokine-prostaglandin signaling, restrict trophoblast invasion, induce apoptosis, and inhibit embryonic and placental growth). Indeed, pregnancy rates are greater in women undergoing standard in vitro fertilization who receive synthetic glucocorticoids prior to or immediately after embryo transfer [54] .
In summary, the results of the present studies established that: HSD11B1 is expressed predominantly in endometrial epithelia, whereas HSD11B2 is expressed predominantly in the conceptus during early pregnancy in sheep; HSD11B1 and PTGS2 expression patterns in the uterine endometrium are coincident with conceptus elongation; P4 induces and IFNT stimulates HSD11B1 expression in endometria; and NR3C1 is present in most cells of the uterus and conceptus during early pregnancy. These results and others support our working hypotheses that ovarian P4, conceptus IFNT, and prostaglandins control HSD11B1 expression in endometrial epithelia and that regenerated cortisol produced by HSD11B1 acts via NR3C1 to regulate endometrial functions important for conceptus elongation and implantation during the periimplantation period of pregnancy.
NOTE ADDED IN PROOF
During the production of this paper, we published further results [55] .
